PT101310A - ANTIGEN IN THE FORM OF PARTICLES AND PROCESS FOR THE PREPARATION OF PARTICLES SIMILAR TO VIRUSES OR PARTICLES SIMILAR TO VIRUS NUCLEUS - Google Patents

ANTIGEN IN THE FORM OF PARTICLES AND PROCESS FOR THE PREPARATION OF PARTICLES SIMILAR TO VIRUSES OR PARTICLES SIMILAR TO VIRUS NUCLEUS

Info

Publication number
PT101310A
PT101310A PT101310A PT10131093A PT101310A PT 101310 A PT101310 A PT 101310A PT 101310 A PT101310 A PT 101310A PT 10131093 A PT10131093 A PT 10131093A PT 101310 A PT101310 A PT 101310A
Authority
PT
Portugal
Prior art keywords
particles
similar
viruses
antigen
preparation
Prior art date
Application number
PT101310A
Other languages
Portuguese (pt)
Inventor
Polly Roy
Original Assignee
Oxford University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929215101A external-priority patent/GB9215101D0/en
Application filed by Oxford University filed Critical Oxford University
Publication of PT101310A publication Critical patent/PT101310A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/23—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a GST-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12111—Orbivirus, e.g. bluetongue virus
    • C12N2720/12122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10123—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT101310A 1992-07-16 1993-07-16 ANTIGEN IN THE FORM OF PARTICLES AND PROCESS FOR THE PREPARATION OF PARTICLES SIMILAR TO VIRUSES OR PARTICLES SIMILAR TO VIRUS NUCLEUS PT101310A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929215101A GB9215101D0 (en) 1992-07-16 1992-07-16 Multiple particulate antigen delivery system
US97115892A 1992-11-04 1992-11-04

Publications (1)

Publication Number Publication Date
PT101310A true PT101310A (en) 1994-05-31

Family

ID=26301262

Family Applications (1)

Application Number Title Priority Date Filing Date
PT101310A PT101310A (en) 1992-07-16 1993-07-16 ANTIGEN IN THE FORM OF PARTICLES AND PROCESS FOR THE PREPARATION OF PARTICLES SIMILAR TO VIRUSES OR PARTICLES SIMILAR TO VIRUS NUCLEUS

Country Status (6)

Country Link
CN (1) CN1084218A (en)
AU (1) AU4773293A (en)
IL (1) IL106362A (en)
MX (1) MX9304310A (en)
PT (1) PT101310A (en)
WO (1) WO1994002173A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1195297A (en) * 1995-07-07 1998-10-07 奥拉瓦克斯有限公司 Clostridium difficile toxins as mucosal adjuvants
JPH11510793A (en) * 1995-07-07 1999-09-21 オラバックス インク． Intranasal vaccination for gastrointestinal disease
US5919463A (en) * 1995-07-07 1999-07-06 Oravax, Inc. Clostridium difficle toxins as mucosal adjuvants
US20040014033A1 (en) 1999-06-30 2004-01-22 Evotec Biosystems Ag, A Corporation Of Germany Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics
US7476517B2 (en) 1999-06-30 2009-01-13 Evotec Ag Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics
AU6267000A (en) * 1999-06-30 2001-01-22 Evotec Oai Ag Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics
DE60037263T2 (en) * 2000-12-29 2008-10-09 Evotec Ag Virus-like particles, their preparation and their use in pharmaceutical screening and functional genome applications
MA44722A (en) * 2016-04-19 2019-02-27 Csir PLANT-PRODUCED CHEMERICAL ORBIVIRUS VLPs

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4722840A (en) * 1984-09-12 1988-02-02 Chiron Corporation Hybrid particle immunogens

Also Published As

Publication number Publication date
CN1084218A (en) 1994-03-23
IL106362A (en) 1998-12-06
WO1994002173A1 (en) 1994-02-03
IL106362A0 (en) 1993-11-15
AU4773293A (en) 1994-02-14
MX9304310A (en) 1995-01-31

Similar Documents

Publication Publication Date Title
BR9200864A (en) AGGLUTINATED ABRASIVE BODIES, ALUMINUM ABRASIVE PARTICLES AND PROCESS FOR ITS PRODUCTION, PROCESS TO IMPROVE THE PERFORMANCE OF ABRASIVE BODY CRUSHING AND ALUMINUM PO PARTICOLES
BR9606992A (en) Process for use in the construction of a garment and processing system
BR9710105A (en) Process for the preparation of polymer particles and sponged articles
KR920700060A (en) Cyclone separator to remove and recover airborne particles
BR9000198A (en) PARTICLE PREPARATION PROCESS AND PARTICLES OBTAINED
BR8707905A (en) VAPORIZATION SYSTEM AND PROCESS TO APPLY MATERIAL IN PARTICLES
BR9007399A (en) COMPOSITION, PROCESS FOR THEIR PREPARATION, PROCESS FOR THE PREPARATION OF FIBROUS PARTICLES AND FIBROUS PARTICLES
PT98944A (en) PROCESS FOR THE PREPARATION OF ALTERED ANTIBODIES AND PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF INFECTIONS
BR9207026A (en) Apparatus and process for wet particle separation
BR9004483A (en) CONNECTED ABRASIVE ARTICLE, PROCESS TO PRODUCE ABRASIVE PARTICLES, AND PROCESS TO IMPROVE CRUSHING PERFORMANCE
BR9303410A (en) CALCINATED Kaolin PIGMENTS, AND PROCESS TO PRODUCE THE SAME
PT101310A (en) ANTIGEN IN THE FORM OF PARTICLES AND PROCESS FOR THE PREPARATION OF PARTICLES SIMILAR TO VIRUSES OR PARTICLES SIMILAR TO VIRUS NUCLEUS
BR8606831A (en) PROCESS FOR THE RECOVERY OF METAL AND COMPOSITES USED IN THE SAME
IT8521921A0 (en) TITANATES IN THE FORM OF SPHERICAL PARTICLES AND PROCESS FOR THEIR PREPARATION.
BR9504387A (en) Process compound for its preparation process to intensify the sun protection factor of materials and use
FR2587989B1 (en) PARTICULATE COMPOSITIONS OF FERROMAGNETIC METAL OXALATES, IN THE FORM OF ACIDULAR SUBMICRON PARTICLES, THEIR PREPARATION AND THEIR APPLICATION
BR9301180A (en) PROCESS FOR THE PREPARATION OF ISOCIANS AND EMPLOYMENT
BR9000155A (en) PROCESS FOR THE PREPARATION OF A MATERIAL IN LOW DENSITY PARTICLES AND SUBSTANTIALLY INSOLUBLE IN WATER AND MATERIAL SO PREPARED
MX21387A (en) COMPOUND AND METHOD TO IMPROVE THE DISPERSABILITY OF MICACEA PARTICLES.
BR9000197A (en) PROCESS OF PREPARATION OF NON-STICKY PARTICLES AND PARTICLES OBTAINED
AU1631188A (en) Newcastle disease virus vaccine and method for the application thereof
BR9007230A (en) PROCESS FOR THE PREPARATION OF 9-SUBSTITUTED GUANINE DERIVATIVES AND INTERMEDIARIES FOR USE IN THE PROCESS
BR8601400A (en) POLYMERIZABLE COMPOSITION AND PROCESS FOR THE PREPARATION OF A PRODUCT IN THE FORM OF A NUCLEUS
BR9004394A (en) SUBSTRATES IN PLATELET FORM FORM LATEX SYSTEM PROCESS FOR ITS PREPARATION, EMPLOYMENT AND FORMULATIONS
BR9301705A (en) FUNGICID COMPOSITES IN PARTICLES AND THE PROCESS OF THEIR PRODUCTION

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19931018

FC3A Refusal

Effective date: 19991202